Appendix 1 -

Distribution of the risk factors in each group.

Variables<32 weeks(n=1703)32–33 weeks(n=2345)34–36 weeks(n=11785)37–41 weeks(199421)P-value*
Maternal age (years)#x00A0;#x00A0;#x00A0;#x00A0;<0.001
<2083 (4.9)123 (5.2)403 (3.4)4584 (2.3)#x00A0;
20–341345 (79.0)1915 (81.7)9864 (83.7)177395 (89.0)#x00A0;
≥35275 (16.1)307 (13.1)1518 (12.9)17442 (8.7)#x00A0;
Parity ≥ 2704 (41.3)905 (38.6)4275 (36.3)59419 (29.8)<0.001
HDP119 (7.0)182 (7.8)706 (6.0)3486 (1.7)<0.001
GDM76 (4.5)100 (4.3)547 (4.6)7020 (3.5)<0.001
ICP12 (0.7)38 (1.6)297 (2.5)1973 (0.5)<0.001
Anemia37 (2.2)61 (2.6)190 (1.6)2407 (1.2)<0.001
Chorioamnionitis48 (2.8)35 (1.5)113 (1.0)787 (0.4)<0.001
Placenta previa47 (2.8)46 (2.0)191 (1.6)6392 (0.2)<0.001
Placental abruption24 (1.4)26 (1.1)46 (0.4)66 (0.0)<0.001
Fetal distress124 (7.3)166 (7.1)542 (4.6)80718 (4.0)<0.001

Values are presented as number and percentages (%).

  • * P-value indicates results of χ2 test comparing proportions of the distribution of risk factors for preterm subgroups. HDP: hypertension disorders in pregnancy, ICP: intrahepatic cholestasis of pregnancy, GDM: gestational diabetes mellitus